2-(4-BROMOPHENYL)-2,3-DIHYDRO-1H-PERIMIDINE, 95%, 100mg

1-(Pyridin-3-yl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 1g

2,4-Dichloroiodobenzene, 98.0%, 25g

1-Methyl-1H-indole-5-sulfonyl chloride, 90.0%, 1g

alpha-Sexithiophene (purified by sublimation)100mg

(6-Fluoropyridin-2-yl)methanamine hydrochloride, 95+%, 100mg

2,4-Dichloro-7-methoxyquinoline, 95.0%, 1g

(Hexahydro-1H-pyrrolizin-7a-yl)methanol, 97%, 1g

3-tert-Butyl-1-methyl-1H-pyrazol-5-amine, 99.0%, 1g

Polyethylene Glycol Monolaurate (n=approx. 10)500g

2-Chloro-1-(4-isobutylphenyl)propan-1-one, 98%, 250mg

TEMPO, mínimo 98 %, para síntesis, 25 g, envase de vidrio

ethyl 2-hydroxy-4-(naphthalen-2-yl)-4-oxobut-2-enoate, 95%, 50mg